Back
ESC2025 Premium Access

Impact of biodegradable-polymer versus durable-polymer drug-eluting stents on clinical outcomes in patients with chronic total occlusion underwent successful percutaneous coronary intervention

Session: Advanced invasive strategies in chronic coronary syndromes
Topic: Revascularisation
Speaker: Doctor M. Susanti (Jawa Timur, ID)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Melly Susanti

Ministry of Health Surabaya Central General Hospital, Jawa Timur (Indonesia)
0 follower

5 more presentations in this session

In-hospital outcomes of left main coronary interventions in high-risk surgical patients:A 12-Year single-center analysis by procedural urgency

Speaker: Doctor B. Abdennadher (Hamburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

The impact of left ventricular ejection fraction on 3-year outcomes in patients with coronary chronic total occlusion

Speaker: Professor Y. Kim (Chuncheon, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Patient selection for chronic total occlusion recanalization in a dedicated outpatient clinic

Speaker: Doctor K. Hamzaraj (Vienna, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

Non-invasive treatment of elderly patients presenting with non-ST segment elevation myocardial infarction (NSTEMI) in a prospective multicenter cohort from Switzerland.

Speaker: Doctor A. Denegri (Parma, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Rotational atherectomy vs. intravascular lithotripsy: a comparative study in the treatment of calcified coronary lesions

Speaker: Doctor H. Chraibi (Rodez, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Advanced invasive strategies in chronic coronary syndromes

Speakers: Doctor M. Susanti, Doctor B. Abdennadher, Professor Y. Kim, Doctor K. Hamzaraj, Doctor A. Denegri...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources